Tilray Brands (TLRY) Long-Term Deferred Tax (2018 - 2026)
Tilray Brands' (TLRY) quarterly Long-Term Deferred Tax came in at $28.0 million in Q2 2026, down 33.78% YoY from $42.3 million in Q2 2025, and down 33.78% on a QoQ basis from $42.3 million in Q2 2025.
Tilray Brands (TLRY) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 4 years of Long-Term Deferred Tax data on file, last reported at $28.0 million in Q2 2026.
- Quarterly Long-Term Deferred Tax fell 33.78% year-over-year to $28.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $28.0 million (down 33.78% YoY) and the FY2026 annual result came in at $28.0 million, down 33.78% from the prior year.
- Long-Term Deferred Tax eased to $28.0 million in Q2 2026, from $42.3 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $113.6 million in Q2 2024 to a low of $28.0 million in Q2 2026.
- A 3-year average of $61.3 million and a median of $42.3 million in 2025 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2025 — Long-Term Deferred Tax tumbled 62.74% — and 2026, when it slumped 33.78%.
- Tracing TLRY's Long-Term Deferred Tax over 3 years: stood at $113.6 million in 2024, then plunged by 62.74% to $42.3 million in 2025, then sank by 33.78% to $28.0 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $28.0 million (Q2 2026), $42.3 million (Q2 2025), and $113.6 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 28.04 Mn |
| May 31, 2025 | 42.34 Mn |
| May 31, 2024 | 113.63 Mn |
| Dec 31, 2018 | 21.10 Mn |